SEC Info - Nymox Pharmaceutical Corp - ‘POS AM’ on 7/30/02

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp – ‘POS AM’ on 7/30/02

On: Tuesday, 7/30/02, at 3:18pm ET · Accession #: 897069-2-530 · File #s: 333-31310 (F-1/A), 333-31310 · Correction: This Filing’s metadata (e.g., “Filed as of” Date) was Corrected by the SEC on 10/3/02. `®`

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/30/02  Nymox Pharmaceutical Corp         POS AM®                3:355K                                   Foley & Lardner/FA

Post-Effective Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: POS AM      Form F-1 Amendment No. 5                             127    550K 
 2: EX-10.7     Research and License Agreement Amendment               3     13K 
 3: EX-23.1     Accountants' Consent                                   1      6K

Filing Submission 0000897069-02-000530 – SGML Text

Click to view...

Original Submission

Correction:

021003-181857

Original SGML Text submitted by:	Foley & Lardner/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Nymox Pharmaceutical Corp – ‘POS AM’ on 7/30/02

On: Tuesday, 7/30/02, at 3:18pm ET · Accession #: 897069-2-530 · File #s: 333-31310 (F-1/A), 333-31310 · Correction: This Filing’s metadata (e.g., “Filed as of” Date) was Corrected by the SEC on 10/3/02. ®

Previous ‘F-1’: ‘F-1/A’ on 3/9/00 · Latest ‘F-1’: This Filing

Post-Effective AmendmentFiling Table of Contents

To view the SGML, please refresh this page.

On: Tuesday, 7/30/02, at 3:18pm ET · Accession #: 897069-2-530 · File #s: 333-31310 (F-1/A), 333-31310 · Correction: This Filing’s metadata (e.g., “Filed as of” Date) was Corrected by the SEC on 10/3/02. `®`

Post-Effective Amendment
Filing Table of Contents

To view the SGML, please refresh
this page.